Schulte JH - Search Results

1

Absence of telomerase reverse transcriptase promoter mutations in neuroblastoma.

Lindner S, Bachmann HS, Odersky A, Schaefers S, Klein-Hitpass L, Hero B, Fischer M, Eggert A, Schramm A, Schulte JH. Lindner S, et al. Among authors: schulte jh. Biomed Rep. 2015 Jul;3(4):443-446. doi: 10.3892/br.2015.463. Epub 2015 May 13. Biomed Rep. 2015. PMID: 26171145 Free PMC article.

2

Microarray-analysis: a new approach to study the molecular mechanisms of thermo-chemotherapy.

Schulte JH, Schramm A, Pressel T, Klein-Hitpass L, Kremens B, Eils J, Havers W, Eggert A. Schulte JH, et al. Klin Padiatr. 2003 Nov-Dec;215(6):298-302. doi: 10.1055/s-2003-45501. Klin Padiatr. 2003. PMID: 14677092

3

Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.

Schulte JH, Schramm A, Klein-Hitpass L, Klenk M, Wessels H, Hauffa BP, Eils J, Eils R, Brodeur GM, Schweigerer L, Havers W, Eggert A. Schulte JH, et al. Oncogene. 2005 Jan 6;24(1):165-77. doi: 10.1038/sj.onc.1208000. Oncogene. 2005. PMID: 15637590

4

Biological effects of TrkA and TrkB receptor signaling in neuroblastoma.

Schramm A, Schulte JH, Astrahantseff K, Apostolov O, Limpt Vv, Sieverts H, Kuhfittig-Kulle S, Pfeiffer P, Versteeg R, Eggert A. Schramm A, et al. Among authors: schulte jh. Cancer Lett. 2005 Oct 18;228(1-2):143-53. doi: 10.1016/j.canlet.2005.02.051. Cancer Lett. 2005. PMID: 15921851 Review.

5

The neurotrophin receptor TrkB cooperates with c-Met in enhancing neuroblastoma invasiveness.

Hecht M, Schulte JH, Eggert A, Wilting J, Schweigerer L. Hecht M, et al. Among authors: schulte jh. Carcinogenesis. 2005 Dec;26(12):2105-15. doi: 10.1093/carcin/bgi192. Epub 2005 Jul 28. Carcinogenesis. 2005. PMID: 16051641

6

Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling.

Schramm A, Schulte JH, Klein-Hitpass L, Havers W, Sieverts H, Berwanger B, Christiansen H, Warnat P, Brors B, Eils J, Eils R, Eggert A. Schramm A, et al. Among authors: schulte jh. Oncogene. 2005 Nov 24;24(53):7902-12. doi: 10.1038/sj.onc.1208936. Oncogene. 2005. PMID: 16103881

7

Translating expression profiling into a clinically feasible test to predict neuroblastoma outcome.

Schramm A, Vandesompele J, Schulte JH, Dreesmann S, Kaderali L, Brors B, Eils R, Speleman F, Eggert A. Schramm A, et al. Among authors: schulte jh. Clin Cancer Res. 2007 Mar 1;13(5):1459-65. doi: 10.1158/1078-0432.CCR-06-2032. Clin Cancer Res. 2007. PMID: 17332289

8

MYCN regulates oncogenic MicroRNAs in neuroblastoma.

Schulte JH, Horn S, Otto T, Samans B, Heukamp LC, Eilers UC, Krause M, Astrahantseff K, Klein-Hitpass L, Buettner R, Schramm A, Christiansen H, Eilers M, Eggert A, Berwanger B. Schulte JH, et al. Int J Cancer. 2008 Feb 1;122(3):699-704. doi: 10.1002/ijc.23153. Int J Cancer. 2008. PMID: 17943719

9

Transcription factor AP2alpha (TFAP2a) regulates differentiation and proliferation of neuroblastoma cells.

Schulte JH, Kirfel J, Lim S, Schramm A, Friedrichs N, Deubzer HE, Witt O, Eggert A, Buettner R. Schulte JH, et al. Cancer Lett. 2008 Nov 18;271(1):56-63. doi: 10.1016/j.canlet.2008.05.039. Epub 2008 Jul 11. Cancer Lett. 2008. PMID: 18620802

10

MicroRNAs in the pathogenesis of neuroblastoma.

Schulte JH, Horn S, Schlierf S, Schramm A, Heukamp LC, Christiansen H, Buettner R, Berwanger B, Eggert A. Schulte JH, et al. Cancer Lett. 2009 Feb 8;274(1):10-5. doi: 10.1016/j.canlet.2008.06.010. Epub 2008 Jul 17. Cancer Lett. 2009. PMID: 18639376 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters